American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative311
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review144
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions120
Prognostic Biomarkers in Evolving Melanoma Immunotherapy106
The Current State of Systemic Therapy of Metastatic Uveal Melanoma90
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE89
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review88
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials84
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma80
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know79
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study77
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments76
The Burden of Pediatric Psoriasis: A Systematic Review75
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study73
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks69
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review68
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution68
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology65
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi64
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?61
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study57
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission57
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation57
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion57
Skin Cancer in Solid Organ Transplant Recipients: A Review57
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients56
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium56
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry55
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment54
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management52
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review51
A Practice Approach to Acne Fulminans in Adolescents50
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!49
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment47
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives46
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances46
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis44
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis43
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis40
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm40
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist39
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review38
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching37
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa36
Oral Lichen Planus: An Update on Diagnosis and Management36
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases36
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis34
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review34
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”32
Frontal Fibrosing Alopecia: An Update30
Individualized Neoantigen-Directed Melanoma Therapy30
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States30
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?30
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists29
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada29
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential28
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History27
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)26
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy26
Targeting Inflammation in Acne: Current Treatments and Future Prospects25
What’s New in Photoprotection?25
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials25
Advancing Precision Medicine in Inflammatory Skin Disease25
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”24
Acknowledgement to Referees24
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials24
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients22
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management21
Management of Acne in Pregnancy20
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis20
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review20
Acknowledgement to Referees20
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea20
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study20
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study19
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year19
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management19
Approach to the Atypical Wound19
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment18
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 18
Real-World Treatment with Lebrikizumab or Tralokinumab for Atopic Dermatitis: A 60-Week Retrospective Comparative Study18
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results18
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials17
Is There a Place for Biologics in Acne?17
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations17
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights17
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts17
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color17
0.34729695320129